Prognostic value of Musashi-1 in gliomas

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)

(2013) Rikke H. Dahlrot et al.   JOURNAL OF NEURO-ONCOLOGY

Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers

(2011) Saskia E. Rademakers et al.   CELLULAR ONCOLOGY

Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma

(2010) Y. V. Bobryshev et al.   DISEASES OF THE ESOPHAGUS

Colon Cancer Stem Cells: Promise of Targeted Therapy

(2010) Matilde Todaro et al.   GASTROENTEROLOGY

The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosisviaNotch-1 and p21WAF1/CIP1

(2010) Martin Götte et al.   INTERNATIONAL JOURNAL OF CANCER

Progenitor stem cell marker expression by pulmonary carcinomas

(2010) Andre L Moreira et al.   MODERN PATHOLOGY

Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma

(2008) D. Beier et al.   CANCER RESEARCH

Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth

(2008) S. Bao et al.   CANCER RESEARCH

Knockdown of RNA Binding Protein Musashi-1 Leads to Tumor Regression In Vivo

(2008) Sripathi M. Sureban et al.   GASTROENTEROLOGY

Presence of pluripotent CD133+ cells correlates with malignancy of gliomas

(2008) Niklas Thon et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

(2008) Prakash Chinnaiyan et al.   Radiation Oncology